1. Home
  2. SVM vs TYRA Comparison

SVM vs TYRA Comparison

Compare SVM & TYRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Silvercorp Metals Inc.

SVM

Silvercorp Metals Inc.

HOLD

Current Price

$9.55

Market Cap

2.2B

ML Signal

HOLD

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

HOLD

Current Price

$32.81

Market Cap

2.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SVM
TYRA
Founded
N/A
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Precious Metals
Biotechnology: Pharmaceutical Preparations
Sector
Basic Materials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
2005
2021

Fundamental Metrics

Financial Performance
Metric
SVM
TYRA
Price
$9.55
$32.81
Analyst Decision
Hold
Strong Buy
Analyst Count
1
11
Target Price
$10.50
$47.50
AVG Volume (30 Days)
4.0M
988.1K
Earning Date
05-25-2026
05-06-2026
Dividend Yield
0.22%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$36.87
N/A
Revenue Next Year
$35.34
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.26
$9.96
52 Week High
$15.77
$40.65

Technical Indicators

Market Signals
Indicator
SVM
TYRA
Relative Strength Index (RSI) 38.98 59.71
Support Level $8.78 $29.68
Resistance Level $13.29 $33.99
Average True Range (ATR) 0.55 1.84
MACD -0.08 0.47
Stochastic Oscillator 29.73 93.67

Price Performance

Historical Comparison
SVM
TYRA

About SVM Silvercorp Metals Inc.

Silvercorp Metals Inc is engaged in the acquisition, exploration, development, and mining of mineral properties. The Company's producing mines are located in China, and current exploration and development projects are located in China, Ecuador and Kyrgyz Republic. The company operates in single segment. The Company mainly produces and sells silver, lead, zinc, gold and other metals. The company's producing projects are Ying Mining District, GC Mine; construction projects are El Domo; permitting project is BYP Mine; development project includes Condor, Tulkubash/Kyzyltash.

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

Share on Social Networks: